Medicare Changes: Exempting Certain Drugs from Discount Program.
This bill aims to exempt certain orally administered drugs from the Medicare Part D manufacturer discount program. This means some medications that previously qualified for discounts might become more expensive for patients or for the Medicare program itself, potentially impacting healthcare costs.
Key points
Exempts specific orally administered drugs from the Medicare Part D manufacturer discount program.
Applies to FDA-approved oral drugs that received a narrow reclassification exception under Medicaid.
Expired
Citizen Poll